While PD-L1 is well established as an immunosuppressive ligand that interacts with PD-1 on T cells to dampen anti-tumor immunity, the observed inverse association implies that high PSD3 expression may coincide with a less immunoevasive phenotype, or alternatively, reflect a compensatory regulatory mechanism within the tumor microenvironment. The gene discussed is PSD3; the disease is neoplasm.